Skip to content

A Prospective, Multicenter, Randomized Controlled, Superiority Clinical Study to Evaluate the Efficacy and Safety of Two Types of Dual-effect Defocus Lenses for Retarding Myopia Progression in Children and Adolescents

A Prospective, Multicenter, Randomized Controlled, Superiority Clinical Study to Evaluate the Efficacy and Safety of Two Types of Dual-effect Defocus Lenses for Retarding Myopia Progression in Children and Adolescents

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117828
Enrollment
Unknown
Registered
2026-01-29
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

Test Group B:Wearing 1.61 multi-point axial control dual-engine defocus lenses for 12 months
Test Group C:Wearing single-vision lenses for 12 months
Test Group A:Wearing 1.56 multi-point fogging dual-effect defocus lenses for 12 months

Sponsors

Children's Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 13 Years

Inclusion criteria

Inclusion criteria: 1. Age 7 to 13 years old (including boundary values), any gender; 2. Under cycloplegic refraction, the subjective spherical equivalent of both eyes is between -1.00D and -5.00D (including boundary values), and the difference in spherical equivalent between both eyes is =1.0; 4. Under cycloplegic refraction, the cylindrical power of both eyes is <=1.50D; 5. Voluntarily participate in this clinical study, sign the informed consent form, and obtain written consent from their guardian.

Exclusion criteria

Exclusion criteria: 1. Individuals with a history of eye trauma or intraocular surgery; 2. Abnormal findings in slit-lamp examination (cornea, conjunctival area); 3. Fundus examination results = grade 2 (see Attachment 2 for details); 4. Intraocular pressure 21 mmHg; 5. Presence of other ocular diseases, such as uveitis or other inflammations, glaucoma, cataracts, fundus diseases, ocular tumors, ocular trauma, or manifest strabismus (prism alternate cover test >15?); 6. Presence of diseases that may affect the eyes (e.g., acute or chronic sinusitis, diabetes, Down syndrome, rheumatoid arthritis, etc.); 7. Individuals with mental disorders or other conditions deemed by the investigator to be unsuitable for wearing prescription glasses; 8. Use of rigid contact lenses, multifocal contact lenses, specially designed myopia control lenses, atropine or similar medications within one month prior to screening or planned during the study period; 9. Participation in other clinical trials within three months prior to screening; 10. Inability to undergo regular eye examinations; 11. Other conditions deemed by the investigator to be unsuitable for participation in this clinical study.

Design outcomes

Primary

MeasureTime frame
Change value of equivalent spherical lens after cycloplegia (objective refraction);

Secondary

MeasureTime frame
Uncorrected Visual Acuity (Near and Distance Vision);Spherical equivalent after cycloplegia (objective refraction);Subjective Refraction without Cycloplegia; Axial Length and Change Value;Stereopsis;Corneal curvature;Subjective experience evaluation with lens wear;

Countries

China

Contacts

Public ContactXu Hua

Children's Hospital of Soochow University

417042378@qq.com+86 137 7190 5386

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026